Effects of all-trans-retinoic acid on human esophageal carcinoma cells and their nuclear matrices

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 563-568

  Wang, Z H ^a   Yam, H F ^a   Or, P C ^a   Yang, L ^a   Ng, K O ^a   Chew Cheng, S B ^a   Jin, M L ^a   Chew, E C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

All trans retinoic acid, and nuclear matrix; EC CUHK1; Esophageal carcinoma

Indexed keywords

NUCLEAR PROTEIN; RETINOIC ACID;

ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS MATRIX; CELL SPECIFICITY; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTINEOPLASTIC AGENTS; ESOPHAGEAL NEOPLASMS; HUMANS; NUCLEAR MATRIX; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0032955779     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Yang CS: Research on esophageal cancer in China: a review. Cancer Res 40: 2633-2644, 1980.
2. Cheng KK: The etiology of esophageal cancer in Chinese. Seminars in Oncol 21: 411-415, 1994.
3. Mahboubi E: The epidemiology of oral cavity, pharyngeal and esophageal cancer outside of North America and West Europe. Cancer 40: 1879-1886, 1977.
4. Stuurman N, Meijne AML, van der Pol AJ, de Jong L, van Driel R, van Renswoude J: The nuclear matrix from cells of different origin. Evidence for a common set of matrix proteins. J Biol Chem 265: 5460-5465, 1990.
5. Getsenberg RH and Coffey DS: Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix proteins. Mol Endocrine 4: 1336-1342, 1990.
6. Fey EG, Penman S: Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc Natl. Acad Sci USA 85: 121-125, 1986.
7. Dworetzky SI, Fey EG, Penman S, Lian JB, Stein JL, Stein GS: Progressive changes in the protein composition of the nuclear matrix during osteoblast differentiation. Proc Natl Acad Sci USA 87: 4605-4609, 1990.
8. McBurney MW, Costa S, Pratt MAC: Retinoids and cancer: A basis for differentiation therapy. Cancer Invest 11: 590-598, 1993.
9. Sporn MB, Roberts AB: Regulation of cell differentiation and proliferation by retinoids and transforming growth factor β, in cell to cell interaction (Burger MM., and Sordat B. Eds.), Karger, Basel, pp.2-15, 1990.
10. Hembree JR, Beard CA, Roshantha AS, Chandratna S, Eckert LR: Retinoid X receptor-specific retinoid inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ecto-cervical epithelial cells. Cancer Res 56: 1794-1700, 1996.
11. Bollag W: Retinoids and cancer. Cancer Chemother Pharmacol 3: 207-215, 1979.
12. Mok CH, Chew EC, Riches DJ, Lee JCK, Huang DP, Hadgis C, Crofts TJ: Biological characterization of a newly established human csophageal carcinoma cell line. Anticancer Res 7: 409-416, 1987.
13. Yang L, Yam HF, Chew-Cheng SB, Cham WK, Lam TW, Chew EC: A morphometric study on the nuclear matrix of tumor cells in vitro. Inter J Onco 8: 977-981, 1996.
14. Fey EG, Wan KM, Penman S: Epithelial cyloskeletal framework and nuclear matrix-intermediate filament scaffold: three-dimensional organization and protein composition. J Cell Biol 98: 1973-1984, 1984.
15. Bollag W, Holdener EE: Retinoids in cancer prevention and therapy. Ann Oncol 3: 513-526, 1992.
16. Lippman SM, Kessler JG, Meyskens FL: Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 71: 493-515, 1987.
17. Moon RC, Mehta RG, Detrisac CJ: Retinoids as chemo-preventive agents for breast cancer. Cancer Detect Prev 16: 73-79, 1992.
18. McBurney MW, Costa S, Pratt MAC: Retinoids and cancer: A basis for differentiation therapy. Cancer Invest 11: 590-598, 1993.
19. Surwit EA, Graham V, Droegemueller W, Alberts D, Chvapil M, Dorr RT, Davis JR, Meyskens FL: Evaluation of topically applied all-trans-retinoic acid in the treatment of cervical intraepithelial lesions. Am J Obstet Gynecol 143: 821-829, 1982.
20. De Stefane V, Teofili L, Sica S, Mastrangelo S, Mario A, Rutella SD, Salutari P, Rumi C, d'Onofrio G, Leone G: Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia. Blood 96: 3535-3541, 1995.
21. Sacks PG, Oke V, Amos R, Vasey T, Lotan R: Modulation of growth, differentiation and glycoprotein synthesis by β-all-trans-retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int J Cancer 44: 926-933, 1989.
22. Lotan R, Nicolson GL: Inhibitory effects of retinoic acid or retinyl acetate on the growth of untransformed, transformed and tumor cells in vitro. J Natl Cancer Inst 59: 1717-1722, 1977.
23. De Luca LM: Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J 5: 2954-2933, 1991.
24. Leid M, Kastner P, Chambon P: Multiplicity generates diversity in the retinoic acid signaling pathways. Trend Biol Sci 17: 427-433, 1992.
25. Yang L, Chew EC, Chew SBC, Yam HF, Loong EPL, Zhai ZH: Electron microscopic analysis of the relationship between nuclear matrix stability and cell differentiation. Anticancer Res 14: 2557-2564, 1994.
26. Berezney R: Organization and functions of the nuclear matrix. In: 'Chromosomal Non-histone Protein'. (L S Hnilica, ed.), Vol.4, pp, 119-180, 1984. CRC Press, Boca Raton, FL.
27. Takahashi N, Breitman TR: Retinoic acid acylation (retinoylation) of a nuclear protein in the human acute myeloid leukemia cell line HL60. J Biol Chem 264: 5159-5163, 1989.
28. Evans RM: The steroid and thyroid hormone receptor family. Science 240: 889-895, 1988.
29. Danielpour D: Induction of transforming growth factor-ß autocrine activity by all-trans-retinoic acid and 1α, 25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells. J Cell Physiol 166: 231-239, 1996.
30. Fernandes D, Catapano CV: The nuclear matrix as a site of anticancer drug action. Int Rev Cytol 162B: 539-576, 1995.